Ipsen(OTC) IPSEY

Market Cap$15.32B

Since IPO (2008)+211%

5 Year+82%

1 Year+50%

1 Month-4%

$45.96

-0.77%

-0.35Today

Ipsen last closing stock price
Metric	Price	Date
Last close	USD 45.96	2026-08-10

Ipsen stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+2.47%	USD 44.85	2026-08-03
1 month	-3.69%	USD 47.72	2026-07-10
3 month	-4.93%	USD 48.35	2026-05-12
Year to date	+27.75%	USD 35.98	2025-12-31
1 year	+49.55%	USD 30.73	2025-08-08
3 year	+45.8%	USD 31.52	2023-08-11
5 year	+81.99%	USD 25.25	2021-08-11
Since inception	+211.42%	USD 14.87	2008-12-12

Ipsen Financials at a Glance

Market Cap

$15.32B

Revenue (TTM)

€7.90B

Net Income (TTM)

€967.70M

EPS (TTM)

$1.80

P/E Ratio

25.63

Dividend

$0.46

Beta (Volatility)

0.16 (Low)

Dividend

$0.46

Beta (Volatility)

0.16 (Low)

Price

$45.96

Volume

1,601

Open

$45.30

Price

$45.96

Volume

1,601

Open

$45.30

Previous Close

$45.96

Daily Range

$45.30 - $45.96

52-Week Range

$31.06 - $51.10

Estimated Earnings Date

Feb 11, 2027

Dividend

$0.46

Beta (Volatility)

0.16 (Low)

Price

$45.96

Volume

1,601

Open

$45.30

Previous Close

$45.96

Daily Range

$45.30 - $45.96

52-Week Range

$31.06 - $51.10

Estimated Earnings Date

Feb 11, 2027

IPSEY News

Exelixis Finally Snags a Licensing Partner for Cometriq

Sean WilliamsMar 1, 2016

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ipsen

Ipsen S.A. is a biopharmaceutical company focused on developing and commercializing innovative medicines in oncology, rare diseases, and neuroscience. With a strong global presence, Ipsen aims to address unmet medical needs through its diverse portfolio of products.

Products and Services

Oncology treatments including Somatuline and Cabometyx
Rare disease medications like Bylvay and Increlex
Neuroscience products such as Dysport for migraine treatment

Growth Outlook

Recent quarterly revenue reached €1.84 billion, showcasing strong market demand
Net income for Q2 2025 was €334 million, reflecting robust profitability
Ongoing clinical trials for innovative therapies may drive future growth

Financial Highlights

TTM revenue of €7.5 billion indicates consistent performance
Operating income margin of 29.5% demonstrates operational efficiency
Dividend yield of 1.01% offers potential income for investors

AI Generated • Jul 25, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,535

CEO

David G. Loew, MBA

Website

www.ipsen.com

Headquarters

Paris, IF 75015, FR

IPSEY Financials

Key Financial Metrics (TTM)

Gross Margin

67.52%

Operating Margin

30.13%

Net Income Margin

12.67%

Return on Equity

11.33%

Return on Capital

13.78%

Return on Assets

6.87%

Earnings Yield

3.90%

Dividend Yield

1.00%

Payout Ratio

25.71%

Stock Overview

Market Cap

$15.32B

Shares Outstanding

330.84M

Volume

1.60K

Avg. Volume

835.857

Financials (TTM)

Gross Profit

€6.09B

Operating Income

€1.64B

EBITDA

€2.56B

Operating Cash Flow

€2.31B

Capital Expenditure

-€860.48M

Free Cash Flow

€1.45B

Cash & ST Invst.

€1.97B

Total Debt

€963.10M

Ipsen Performance Analysis

Ipsen annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 3,179,197,308	1.8%
2023	2023-12-31	EUR 3,381,189,048	6.4%
2024	2024-12-31	EUR 3,678,397,586	8.8%
2025	2025-12-31	EUR 4,148,539,689	12.8%

Ipsen sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2024-12-31	4.0%
Q2	2025-06-30	6.3%
Q4	2025-12-31	-4.9%
Q2	2026-06-30	24.8%

Ipsen annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 2.05	-10.5%
2023	2023-12-31	EUR 2.09	1.9%
2024	2024-12-31	EUR 1.12	-46.3%
2025	2025-12-31	EUR 1.50	33.8%

Ipsen sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2024-12-31	-52.8%
Q2	2025-06-30	192.0%
Q4	2025-12-31	-72.2%
Q2	2026-06-30	347.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€2.30B

+31.2%

Gross Profit

€1.66B

+16.0%

Gross Margin

72.40%

N/A

Market Cap

$15.32B

N/A

Market Cap/Employee

$2.77M

N/A

Employees

5,535

N/A

Net Income

€411.11M

+77.2%

EBITDA

€816.40M

+69.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€1.97B

+305.7%

Total Debt

€963.10M

+96.5%

Accounts Receivable

€999.39M

+39.0%

Inventory

€201.22M

-26.2%

Long Term Debt

€701.40M

+97.5%

Short Term Debt

€259.70M

+92.2%

Return on Assets

6.87%

N/A

Return on Invested Capital

21.29%

N/A

Free Cash Flow

€664.65M

+63.4%

Operating Cash Flow

€693.61M

+48.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CHALFChalice Brands Ltd

CHALFChalice Brands Ltd$0.00+0.00%

DSKYFDaiichi Sankyo Company, Limited

DSKYFDaiichi Sankyo Company, Limited$17.40-0.85%

DSNKYDaiichi Sankyo Company, Limited

DSNKYDaiichi Sankyo Company, Limited$17.71+0.91%

HLNCFHaleon plc

HLNCFHaleon plc$4.89-1.31%

UCBJYUCB S.A.

UCBJYUCB S.A.$129.94+0.60%

TKPHFTakeda Pharmaceutical Company Limited

TKPHFTakeda Pharmaceutical Company Limited$32.53-9.36%

HOCPFHOYA Corporation

HOCPFHOYA Corporation$175.38+9.91%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$138.74+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.26+0.12%

NVDANvidia

NVDANvidia$217.55-0.03%

INTCIntel

INTCIntel$97.52-0.04%

ONDSOndas

ONDSOndas$9.31+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$8.21+0.01%

RIGTransocean

RIGTransocean$5.72+0.09%

Questions About IPSEY

What is the current price of Ipsen?

Ipsen is trading at $45.96 per share.

What is the 52-week range for Ipsen?

Over the past 52 weeks, Ipsen has traded between $31.06 and $51.10.

How much debt does Ipsen have?

As of the most recent reporting period, Ipsen reported total debt of €1.14B.

How much cash does Ipsen have on hand?

Ipsen reported €1.79B in cash and cash equivalents in its most recent financial results.

What is Ipsen’s dividend yield?

Ipsen currently has a dividend yield of 1.00%.

Ipsen(OTC) IPSEY

Ipsen Financials at a Glance

IPSEY News

Exelixis Finally Snags a Licensing Partner for Cometriq

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ipsen

IPSEY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ipsen Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IPSEY

What is the current price of Ipsen?

What is the 52-week range for Ipsen?

How much debt does Ipsen have?

How much cash does Ipsen have on hand?

What is Ipsen’s dividend yield?

Premium Investing Services